Literature DB >> 11983318

Drug-induced rotation intensity in unilateral dopamine-depleted rats is not correlated with end point or qualitative measures of forelimb or hindlimb motor performance.

G A Metz1, I Q Whishaw.   

Abstract

The pharmacological induction of rotational (circling) behavior is widely used to assess the effects of lesions to the dopaminergic system and the success of treatment strategies in rat models of Parkinson's disease. While the number of rotations under apomorphine, L-DOPA and amphetamine is related to the extent of dopamine depletion after unilateral 6-hydroxydopamine lesion of the nigrostriatal dopamine system, the relationship of the intensity of rotational behavior to the degree of impairment in motor behavior is unclear. The present study examined this question by correlating rotational behavior and motor abilities in a rat analogue for Parkinson's disease produced by unilateral nigrostriatal bundle lesion with 6-hydroxydopamine. Ipsiversive and contraversive rotation was measured in the rats following systemic administration of low and high doses of apomorphine, the dopamine precursor L-DOPA, and amphetamine. The motor assessment included end point and qualitative measures of fore- and hindlimbs assessed in a skilled reaching task and a skilled ladder rung walking task. The intensity of drug-induced rotation did not correlate with the measures of motor performance. We conclude that independence of rotational behavior and motor performance argues that both the assessment of 6-hydroxydopamine behavioral deficits and potential treatments for the functional deficits require comprehensive assessment, including both measures of rotation and motor behavior.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11983318     DOI: 10.1016/s0306-4522(02)00013-1

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  18 in total

1.  Sex differences in skilled movement in response to restraint stress and recovery from stress.

Authors:  Nafisa M Jadavji; Gerlinde A Metz
Journal:  Behav Brain Res       Date:  2008-09-19       Impact factor: 3.332

2.  Discovery of Novel Cell Surface Markers for Purification of Embryonic Dopamine Progenitors for Transplantation in Parkinson's Disease Animal Models.

Authors:  Ali Fathi; Mehdi Mirzaei; Banafsheh Dolatyar; Mehdi Sharifitabar; Mahnaz Bayat; Ebrahim Shahbazi; Jaesuk Lee; Mohammad Javan; Su-Chun Zhang; Vivek Gupta; Bonghee Lee; Paul A Haynes; Hossein Baharvand; Ghasem Hosseini Salekdeh
Journal:  Mol Cell Proteomics       Date:  2018-05-29       Impact factor: 5.911

3.  Relationships among rat ultrasonic vocalizations, behavioral measures of striatal dopamine loss, and striatal tyrosine hydroxylase immunoreactivity at acute and chronic time points following unilateral 6-hydroxydopamine-induced dopamine depletion.

Authors:  Laura M Grant; David G Barnett; Emerald J Doll; Glen Leverson; Michelle Ciucci
Journal:  Behav Brain Res       Date:  2015-05-27       Impact factor: 3.332

4.  LPA signaling is required for dopaminergic neuron development and is reduced through low expression of the LPA1 receptor in a 6-OHDA lesion model of Parkinson's disease.

Authors:  Xiao-Yun Yang; Ethan Y Zhao; Wen-Xin Zhuang; Feng-Xiang Sun; Hai-Lin Han; Hui-Rong Han; Zhi-Juan Lin; Zhi-Fang Pan; Mei-Hua Qu; Xian-Wei Zeng; Yuchuan Ding
Journal:  Neurol Sci       Date:  2015-07-14       Impact factor: 3.307

5.  Intracarotid Infusion of Mesenchymal Stem Cells in an Animal Model of Parkinson's Disease, Focusing on Cell Distribution and Neuroprotective and Behavioral Effects.

Authors:  Silvia Cerri; Rosaria Greco; Giovanna Levandis; Cristina Ghezzi; Antonina Stefania Mangione; Marie-Therese Fuzzati-Armentero; Arianna Bonizzi; Maria Antonietta Avanzini; Rita Maccario; Fabio Blandini
Journal:  Stem Cells Transl Med       Date:  2015-07-21       Impact factor: 6.940

6.  Neuroprotective Activities of Spirulina platensis in the 6-OHDA Model of Parkinson's Disease Are Related to Its Anti-Inflammatory Effects.

Authors:  Francisco Arnaldo Viana Lima; Ivan Pinheiro Joventino; Francisca Pinheiro Joventino; Aline Cordeiro de Almeida; Kelly Rose Tavares Neves; Marta Regina do Carmo; Luzia Kalyne Almeida Moreira Leal; Geanne Matos de Andrade; Glauce Socorro de Barros Viana
Journal:  Neurochem Res       Date:  2017-08-31       Impact factor: 3.996

7.  NMDA receptor antagonists ameliorate the stepping deficits produced by unilateral medial forebrain bundle injections of 6-OHDA in rats.

Authors:  John E Kelsey; Stephen D Mague; Reyna S Pijanowski; Ryan C Harris; Nancy W Kleckner; Russell T Matthews
Journal:  Psychopharmacology (Berl)       Date:  2004-03-06       Impact factor: 4.530

8.  Stress accelerates neural degeneration and exaggerates motor symptoms in a rat model of Parkinson's disease.

Authors:  Lori K Smith; Nafisa M Jadavji; Keri L Colwell; S Katrina Perehudoff; Gerlinde A Metz
Journal:  Eur J Neurosci       Date:  2008-04       Impact factor: 3.386

9.  Nafamostat Mesilate Improves Neurological Outcome and Axonal Regeneration after Stroke in Rats.

Authors:  Yuan Liu; Chenhui Li; Jing Wang; Yinquan Fang; Hao Sun; Xia Tao; Xin-Fu Zhou; Hong Liao
Journal:  Mol Neurobiol       Date:  2016-06-22       Impact factor: 5.590

10.  The ladder rung walking task: a scoring system and its practical application.

Authors:  Gerlinde A Metz; Ian Q Whishaw
Journal:  J Vis Exp       Date:  2009-06-12       Impact factor: 1.355

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.